Covid-19 drug from Singapore-based firm to enter final trials soon

  • 📰 thenewpaper
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Trials for a potential treatment for Covid-19 are being accelerated, with the third and final phase for the drug due to start in a few weeks' time. Developed by Singapore-based biotechnology company Tychan, the monoclonal antibody - or immune system protein - known as TY027...

Monoclonal antibodies are immune system proteins that are created in the laboratory and can be specially designed and engineered to target Sars-CoV-2.

Half of the 500 patients will receive a placebo in the double-blind trial so that the drug's effectiveness can be tested, said Prof Ooi. Tychan will work with hospitals under SingHealth to recruit the patients.The recruitment process has not started yet because the final trial is pending approval from the authorities.

Clinical trials are commonly conducted in four phases, beginning with a small group to test the drug's safety and side effects, then moving on to larger groups to determine its efficacy. TY027 is being explored for the treatment of Covid-19 patients in slowing the progression of the disease and speeding up recovery, as well as potentially providing temporary protection against infection.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 7. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Human trials of COVID-19 vaccine set to begin in IndonesiaHuman trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Israel institute to start COVID-19 vaccine trials in humans soonJERUSALEM: An Israeli research institute that is overseen by the Defence Ministry intends to begin human trials for a potential COVID-19 vaccine ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

COVID-19: Singapore confirms 908 new cases as final batch from dormitories being clearedThe Ministry of Health has confirmed 908 new COVID-19 cases as of Wednesday (5 August) noon, bringing Singapore’s total to 54,254.
Source: YahooSG - 🏆 3. / 71 Read more »

Singapore reports 301 new COVID-19 cases, including 4 in the communitySINGAPORE: Singapore reported 301 new COVID-19 cases as of noon on Thursday (Aug 6), the Ministry of Health (MOH) said in its preliminary daily ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

3 locals among 301 new COVID-19 cases in Singapore; total at 54,555The Ministry of Health (MOH) has confirmed 301 new COVID-19 cases as of Thursday (6 August), bringing Singapore’s total to 54,555.
Source: YahooSG - 🏆 3. / 71 Read more »

Singapore will get first claim to any successful Arcturus Covid-19 vaccine[SINGAPORE] Singapore sought out US Covid-19 vaccine developer Arcturus Therapeutics Holdings and is funding its research in order to secure the first doses of any successful final product, in a reflection of the growing urgency in the race for immunisation. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »